Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?

L. Bartalena, G. Veronesi, G. E. Krassas, W. M. Wiersinga, C. Marcocci, M. Marinò, M. Salvi, C. Daumerie, C. Bournaud, M. Stahl, L. Sassi, C. Azzolini, K. G. Boboridis, M. P. Mourits, M. R. Soeters, L. Baldeschi, M. Nardi, N. Currò, A. Boschi, M. BernardG. von Arx, P. Perros, G. J. Kahaly, on behalf of the European Group on Graves’ Orbitopathy (EUGOGO)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?'. Together they form a unique fingerprint.

Medicine & Life Sciences